Global Cancer Immunotherapy Market & Clinical Trials Outlook 2017-2022: Currently, there are more than 2000 cancer …GlobeNewswire (press release)Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 report gives comprehensive insi… Continue reading
|
Global Cancer Immunotherapy Market & Clinical Trials Outlook 2017 …
Yahoo Finance Dublin, May 01, 2017– Research and Markets has announced the addition of the “Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022” report to … |
USC News |
From pro volleyball to biology: USC scientist is at the top of his game
USC News “Synthetic biology is pretty much trying to bring the engineering approach of building things into biology,” Morsut said. “You think about the biological system not as something that you want to learn about, but as something that you want to use to … |
Genetic Literacy Project |
Glowing Plant’s failed Kickstarter venture highlights pitfalls of synthetic biology
Genetic Literacy Project In the four years since Glowing Plant began, synthetic biology has caught the eye of investors. “Glowing Plant was iconic,” says Ryan Bethencourt, the program director at IndieBio, an accelerator for biology startups. “That was one the things that made … |
Genetic Literacy Project |
Glowing Plant’s failed Kickstarter venture highlights pitfalls of synthetic biology
Genetic Literacy Project In the four years since Glowing Plant began, synthetic biology has caught the eye of investors. “Glowing Plant was iconic,” says Ryan Bethencourt, the program director at IndieBio, an accelerator for biology startups. “That was one the things that made … |
SMA News Today |
AveXis Seeks FDA Blessing to Manufacture AVXS-101 Gene Therapy to Treat SMA Type 1 Babies
SMA News Today Specifically, AveXis wants the FDA to approve its manufacturing process for AVXS-101, its SMA gene therapy, at the May 1 meeting, and to assure the regulatory body that the drug’s quantity and quality is sufficient to meet demand. AveXis hopes to … |